Production (Stage)
Travere Therapeutics, Inc.
TVTX
$15.84
$0.140.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 322.24M | 370.70M | 277.44M | 325.40M | 441.04M |
| Total Receivables | 36.48M | 29.42M | 27.67M | 27.27M | 26.53M |
| Inventory | 3.93M | 6.20M | 6.36M | 5.98M | 4.53M |
| Prepaid Expenses | 11.52M | 10.39M | 13.28M | 10.34M | 8.97M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 374.17M | 416.70M | 324.74M | 368.98M | 481.08M |
|
|
|||||
| Total Current Assets | 374.17M | 416.70M | 324.74M | 368.98M | 481.08M |
| Net Property, Plant & Equipment | 18.05M | 19.63M | 21.82M | 23.05M | 24.21M |
| Long-term Investments | 753.00K | 753.00K | 747.00K | 753.00K | 753.00K |
| Goodwill | 753.00K | 753.00K | 747.00K | 753.00K | 753.00K |
| Total Other Intangibles | 103.06M | 103.22M | 103.46M | 104.42M | 100.43M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 52.76M | 53.82M | 53.64M | 53.92M | 57.08M |
| Total Assets | 548.80M | 594.13M | 504.41M | 551.12M | 663.55M |
|
|
|||||
| Total Accounts Payable | 15.37M | 23.53M | 23.20M | 25.84M | 16.73M |
| Total Accrued Expenses | 77.11M | 86.03M | 83.56M | 78.59M | 138.38M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 74.22M | 74.08M | 73.90M | 5.16M | 5.04M |
| Total Finance Division Other Current Liabilities | 15.76M | 17.11M | 9.39M | 11.68M | 13.09M |
| Total Other Current Liabilities | 15.76M | 17.11M | 9.39M | 11.68M | 13.09M |
| Total Current Liabilities | 182.46M | 200.75M | 190.04M | 121.27M | 173.23M |
|
|
|||||
| Total Current Liabilities | 182.46M | 200.75M | 190.04M | 121.27M | 173.23M |
| Long-Term Debt | 310.66M | 310.31M | 309.96M | 378.13M | 377.69M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 15.58M | 17.19M | 18.58M | 19.94M | 21.29M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.27M | 6.80M | 16.29M | 16.64M | 17.27M |
| Total Liabilities | 515.98M | 535.05M | 534.86M | 535.97M | 589.48M |
|
|
|||||
| Common Stock & APIC | 1.52B | 1.51B | 1.36B | 1.35B | 1.34B |
| Retained Earnings | -1.49B | -1.45B | -1.39B | -1.33B | -1.26B |
| Treasury Stock & Other | -843.00K | -80.00K | -1.02M | -1.63M | -1.89M |
| Total Common Equity | 32.82M | 59.08M | -30.45M | 15.15M | 74.07M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 32.82M | 59.08M | -30.45M | 15.15M | 74.07M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 32.82M | 59.08M | -30.45M | 15.15M | 74.07M |
|
|
|||||